Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (238 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
39.46
4,52,982
76.15
1,64,737
29.81
1,15,655
22.74
1,14,613
26.83
1,12,573
21.07
1,12,363
53.74
1,02,795
25.56
89,581
29.13
67,048
167
64,683
46.08
62,757
35.92
56,236
39.15
44,676
38.80
40,971
39.41
40,825
55.09
39,082
37.23
34,412
139
29,656
93.20
22,995
35.73
21,258
28.67
20,795
108
20,375
31.63
19,594
29.96
19,210
-
18,467
12.22
17,332
50.88
16,390
23.63
15,943
50.55
13,190
65.25
12,080
28.57
11,941
29.68
11,907
66.78
11,839
47.80
11,632
31.83
10,503
40.53
10,435
39.87
10,175
17.89
9,951
44.45
9,764
52.24
9,032
5.65
8,775
-
8,378
25.12
7,744
24.34
6,849
56.12
6,474
39.87
5,619
41.89
5,409
246
5,071
-
4,893
35.55
4,893
35.30
4,066
85.43
4,054
15.92
4,025
59.32
3,809
37.07
3,780
21.11
3,561
18.15
3,537
34.05
3,230
-
3,226
39.35
2,650
181
2,586
-
2,291
22.16
2,278
7.10
2,254
53.39
2,215
41.30
1,988
47.09
1,950
58.40
1,780
31.88
1,774
25.59
1,701
26.86
1,563
34.99
1,518
67.30
1,464
43.58
1,422
19.63
1,291
16.81
1,285
22.58
1,258
13.80
1,213
40.68
1,179
26.83
1,177
52.72
1,137
14.99
1,076
902
1,032
41.67
971
21.84
939
-
917
24.17
894
49.97
887
34.15
879
29.05
817
27.53
805
18.89
792
48.46
724
32.83
674
21.06
635
106
621
26.10
525
28.06
510
44.25
491
13.94
484
27.07
469
22.49
461
-
393
81.76
378
68.53
357
-
345
35.54
343
24.60
320
16.29
310
27.60
304
51.25
300
32.04
290
63.24
286
-
278
-
250
62.67
249
13.55
241
44.62
220
19.99
220
10.50
220
12.70
219
-
217
103
215
12.57
215
-
211
8.38
206
10.34
203
110
195
35.29
179
26.07
177
-
173
17.66
171
660
171
13.85
163
12.14
158
14.27
155
20.99
152
15.43
151
19.53
148
-
148
41.72
147
9.81
147
9.58
144
40.52
137
27.04
137
93.51
132
18.62
129
21.22
129
32.19
128
19.69
124
30.95
122
65.79
119
-
117
-
117
13.23
112
19.26
111
25.45
104
24.24
98
91.48
97
19.94
96
38.09
90
7.55
86
21.60
85
11.77
81
20.72
78
-
78
136
74
-
72
-
70
35.89
69
3.85
68
16.52
64
-
62
35.00
55
19.57
55
12.29
52
10.73
52
-
51
16.05
50
-
48
19.70
46
-
46
5.05
46
-
44
99.65
44
-
44
-
43
9.84
41
25.76
40
87.29
39
466
39
-
37
19.13
37
5.39
34
-
33
-
32
12.75
32
10.58
32
12.73
32
51.55
31
24.13
29
8.21
28
4.70
28
-
28
-
28
12.08
27
29.36
25
18.24
23
-
23
-
22
-
21
82.96
21
-
21
28.13
21
32.99
19
-
19
32.66
17
142
17
3,396
17
-
15
-
13
-
13
29.34
13
7.79
13
28.59
12
142
11
12.87
9
-
8
-
8
-
8
89.76
7
83.79
7
-
7
-
5
69.81
4
-
4
-
3
-
2
Showing 5 238 of 238 Show More
Market Share

    Select a Metric
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Fermentation Based API Products - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Vaccines - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Capacity Utilization - Benzimidazole (%)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material